Upgrade to SI Premium - Free Trial

Celldex Therapeutics (CLDX) PT Lowered to $60 at Canaccord

July 22, 2026 6:39 AM
(Updated - July 22, 2026 7:41 AM EDT)

Canaccord analyst Ed Nash lowered the price target on Celldex Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change